Steven Cohen Pacific Biosciences Of California, Inc. Transaction History

Point72 Asset Management, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $16.4 Million - $28.5 Million	2,755,364 Added 106.23%	5,349,146 $52.5 Million
Q3 2023 Nov 14, 2023	SELL	$8.23 - $13.93 $33.5 Million - $56.7 Million	-4,067,851 Reduced 61.06%	2,593,782 $21.7 Million
Q2 2023 Aug 14, 2023	SELL	$9.97 - $14.05 $6.26 Million - $8.82 Million	-627,735 Reduced 8.61%	6,661,633 $88.6 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $15.5 Million - $23.5 Million	1,957,373 Added 36.71%	7,289,368 $84.4 Million
Q4 2022 Feb 14, 2023	BUY	$5.67 - $11.2 $15.9 Million - $31.3 Million	2,797,889 Added 110.41%	5,331,995 $43.6 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $9.96 Million - $21.7 Million	2,534,106 New	2,534,106 $14.7 Million
Q1 2021 May 17, 2021	SELL	$26.38 - $51.15 $1.06 Million - $2.05 Million	-40,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $23.9 Million - $64.7 Million	-2,271,631 Reduced 98.27%	40,000 $1.04 Million
Q3 2020 Nov 16, 2020	BUY	$3.61 - $9.87 $8.34 Million - $22.8 Million	2,311,631 New	2,311,631 $22.8 Million
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $20.6 Million - $40.5 Million	-5,175,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.52 - $5.55 $8.01 Million - $12.6 Million	2,275,000 Added 78.45%	5,175,000 $28 Million
Q2 2018 Aug 14, 2018	BUY	$2.11 - $3.92 $1.69 Million - $3.14 Million	800,000 Added 38.1%	2,900,000 $10.3 Million
Q1 2018 May 15, 2018	BUY	$2.05 - $3.23 $4.31 Million - $6.78 Million	2,100,000 New	2,100,000 $4.31 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.